Clinical trial
A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS…
NCT00251797 · University of New Mexico, Other · Completed
Key facts
| NCT number | NCT00251797 |
|---|---|
| Title | A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors |
| Official title | A Phase I Trial Using Combination Irinotecan and Thalidomide for Recurrent CNS Tumors. |
| Lead sponsor | University of New Mexico, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Nervous System, Cancer |
| Intervention type | Drug |
| Interventions | Irinotecan, Thalidomide |
| Enrollment | 10 |
| Start date | Mar 1, 2000 |
| Primary completion | Jun 1, 2006 |
| Completion | Jun 1, 2006 |
| First posted | Nov 10, 2005 |
| Last update posted | Jan 7, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: